Single award · contract
Addressing the COVID-19 Pandemic: Urgent Priorities
Award ID: 75A50121C00009
FY2021 · complete year · data as of 2026-07-12
A single federal award, with both ends of the trail linked.
$102.3M
Total award value
Award 75A50121C00009 is a contract from the Department of Health and Human Services to Merck Sharp & Dohme LLC, $102.3M obligated, FY2021 to FY2022, for Addressing the COVID-19 Pandemic: Urgent Priorities. The work is performed in North Carolina. It is classified as NAICS 325414 (Biological Product (except Diagnostic) Manufacturing) and PSC Z2EC (Repair or Alteration of Production Buildings). Source
Award details
Award typeContract
PIID75A50121C00009
Action date2021
Period12 mo
Awarding agencyDepartment of Health and Human Services →
RecipientMerck Sharp & Dohme LLC →
Place of performanceNorth Carolina →
CategoryNAICS 325414PSC Z2EC
Competed?Not recordedSource
Total (exact)$102,299,549
More awards to Merck Sharp & Dohme LLC
awarded 2021$2.2B
awarded 2014$1.5B
awarded 2017$1.5B
awarded 2013$1.4B
awarded 2012$1.4B
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.